Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Short-term Investments (2018 - 2025)

Dna X's Short-term Investments history spans 7 years, with the latest figure at $2.2 million for Q3 2025.

  • Quarterly results put Short-term Investments at $2.2 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $2.2 million (changed N/A YoY), and the annual figure for FY2024 was $2.7 million, up 1269.04%.
  • Short-term Investments for Q3 2025 was $2.2 million at Dna X, down from $3.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $3.4 million in Q2 2025 to a low of $197000.0 in Q4 2023.
  • The 4-year median for Short-term Investments is $2.4 million (2024), against an average of $2.1 million.
  • The sharpest move saw Short-term Investments decreased 8.12% in 2021, then skyrocketed 1269.04% in 2024.
  • Year by year, Short-term Investments stood at $1.0 million in 2021, then tumbled by 81.08% to $197000.0 in 2023, then skyrocketed by 1269.04% to $2.7 million in 2024, then decreased by 18.95% to $2.2 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $2.2 million, $3.4 million, and $2.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.